BIOMAT Database Logo BIOMAT Database Logo

The clinical importance of alloantibody-mediated rejection. 2003

Philip F Halloran

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Philip F Halloran
Chronic alloantibody mediated rejection.
April 2012, Seminars in immunology,
Philip F Halloran
Chronic histiocytic intervillositis: manifestation of placental alloantibody-mediated rejection.
December 2021, American journal of obstetrics and gynecology,
Philip F Halloran
Prevention and treatment of alloantibody-mediated kidney transplant rejection.
December 2011, Transplant international : official journal of the European Society for Organ Transplantation,
Philip F Halloran
Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation.
December 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Philip F Halloran
Mode of alloantibody-mediated blockade of allo-sensitization for tumor allograft rejection.
March 1989, Immunobiology,
Philip F Halloran
B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
January 2006, Clinical transplantation,
Philip F Halloran
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.
February 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Philip F Halloran
Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
July 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Philip F Halloran
Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?
March 2016, Clinical biochemistry,
Philip F Halloran
Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.
October 2012, Transplant immunology,
Copied contents to your clipboard!